{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:13:42Z","timestamp":1777536822399,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:00:00Z","timestamp":1685318400000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Public Assistance Hospitals Paris","doi-asserted-by":"publisher","award":["AOM04021"],"award-info":[{"award-number":["AOM04021"]}],"id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"Public Assistance Hospitals Paris","doi-asserted-by":"publisher","award":["AOM00139"],"award-info":[{"award-number":["AOM00139"]}],"id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-17-EURE-0017"],"award-info":[{"award-number":["ANR-17-EURE-0017"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-INBS-0011"],"award-info":[{"award-number":["ANR-11-INBS-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.neurol.2022.03.004","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T17:08:50Z","timestamp":1651165730000},"page":"441-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["What did we learn from neural grafts in Huntington disease?"],"prefix":"10.1016","volume":"178","author":[{"given":"A.-C.","family":"Bachoud-L\u00e9vi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2022.03.004_bib0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2022.03.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102211","article-title":"Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes","volume":"26","author":"Mangin","year":"2020","journal-title":"Neuroimage Clin"},{"issue":"4","key":"10.1016\/j.neurol.2022.03.004_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JHD-160221","article-title":"Dysregulation of corticostriatal connectivity in Huntington's disease: a role for dopamine modulation","volume":"5","author":"Rangel-Barajas","year":"2016","journal-title":"J Huntingtons Dis"},{"issue":"2","key":"10.1016\/j.neurol.2022.03.004_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3174\/ajnr.A3303","article-title":"Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up","volume":"34","author":"van den Bogaard","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"Pt 6","key":"10.1016\/j.neurol.2022.03.004_bib0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/brain\/awh145","article-title":"Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease","volume":"127","author":"Peschanski","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.03.004_bib0030","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/35104055","article-title":"The influence of environment and experience on neural grafts","volume":"2","author":"S.B.","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurol.2022.03.004_bib0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0079-6123(00)27017-9","article-title":"The integration and function of striatal grafts","volume":"127","author":"Dunnett","year":"2000","journal-title":"Prog Brain Res"},{"issue":"5","key":"10.1016\/j.neurol.2022.03.004_bib0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/WNP.0b013e3181baaab9","article-title":"Noninvasive correlates of subdural grid electrographic outcome","volume":"26","author":"Kalamangalam","year":"2009","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2022.03.004_bib0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nm0898-963","article-title":"Foetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease","volume":"4","author":"Palfi","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2022.03.004_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.pbr.2016.12.011","article-title":"From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies","volume":"230","author":"Bachoud-L\u00e9vi","year":"2017","journal-title":"Prog Brain Res"},{"issue":"9246","key":"10.1016\/j.neurol.2022.03.004_bib0055","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after neural transplantation","volume":"356","author":"Bachoud-Levi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2022.03.004_bib0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/exnr.1999.7239","article-title":"Safety assessment of intrastriatal neural allografts in 5 patients with Huntington's disease","volume":"161","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2022.03.004_bib0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mds.10117","article-title":"Fetal neural grafts for Huntington's disease: a prospective view","volume":"17","author":"Bachoud-Levi","year":"2002","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.neurol.2022.03.004_bib0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of f\u0153tal neural transplants in patients with Hungtington's disease 6 years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-L\u00e9vi","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Pt 1","key":"10.1016\/j.neurol.2022.03.004_bib0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington's disease patients","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neurol.2022.03.004_bib0080","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jnnp.2007.142380","article-title":"Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease","volume":"79","author":"Reuter","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.neurol.2022.03.004_bib0085","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/mds.28201","article-title":"Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II","volume":"35","author":"Bachoud-L\u00e9vi","year":"2020","journal-title":"Trial Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2022.03.004_bib0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency","volume":"11","author":"Huntington Study Group","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2022.03.004_bib0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/aws359","article-title":"Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability","volume":"136","author":"Cisbani","year":"2013","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurol.2022.03.004_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000166","article-title":"Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease","volume":"2","author":"Krystkowiak","year":"2007","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.neurol.2022.03.004_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2010.08.031","article-title":"Technical factors that influence neural transplant safety in Huntington's disease","volume":"227","author":"Freeman","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2022.03.004_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1759-1961.2011.00018.x","article-title":"Immune response after striatal engrafment of fetal neuronal cells in patients with Huntington\u2019 s disease: Consequences for cerebral transplantation programs","volume":"2","author":"Krebs","year":"2011","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.neurol.2022.03.004_bib0115","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jnnp-2013-306533","article-title":"Fetal striatal grafting slows motor and cognitive decline of Huntington's disease","volume":"85","author":"Paganini","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.neurol.2022.03.004_bib0120","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3727\/096368914X685429","article-title":"Translation of cell therapies to the clinic: characteristics of cell suspensions in large-diameter injection cannulae","volume":"24","author":"Torres","year":"2015","journal-title":"Cell Transplant"},{"issue":"24","key":"10.1016\/j.neurol.2022.03.004_bib0125","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","article-title":"Neural transplantation in Huntington disease: long-term grafts in two patients","volume":"68","author":"Keene","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.03.004_bib0130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3171\/jns.1998.89.4.0592","article-title":"Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease","volume":"89","author":"Mamelak","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neurol.2022.03.004_bib0135","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's Disease after intracerebral transplantation","volume":"356","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Lancet"},{"issue":"38","key":"10.1016\/j.neurol.2022.03.004_bib0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1126\/scitranslmed.3000976","article-title":"Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants","volume":"2","author":"Politis","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurol.2022.03.004_bib0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3727\/096368913X676222","article-title":"Donor-Specific Anti-HLA Antibodies in Huntington's Disease Recipients of Human Fetal Striatal Grafts","volume":"24","author":"Porfirio","year":"2015","journal-title":"Cell Transplant"},{"issue":"30","key":"10.1016\/j.neurol.2022.03.004_bib0150","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.neurol.2022.03.004_bib0155","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"New Eng J Med"},{"issue":"3","key":"10.1016\/j.neurol.2022.03.004_bib0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.neurol.2022.03.004_bib0165","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1474-4422(09)70278-9","article-title":"Neural grafts in Huntington's disease: viability after 10 years","volume":"8","author":"Bachoud-Levi","year":"2009","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2022.03.004_bib0170","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/WNL.56.8.1052","article-title":"Retest effects and cognitive decline in longitudinal follow-up of patients with early HD","volume":"56","author":"Bachoud-Levi","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.03.004_bib0175","unstructured":"ISSCR, Guidelines for Stem Cell Research and Clinical Translation. https:\/\/www.isscr.org\/docs\/default-source\/all-isscr-guidelines\/2021-guidelines\/isscr-guidelines-for-stem-cell-research-and-clinical-translation-2021.pdf?sfvrsn=979d58b1_4, 2021."},{"issue":"13","key":"10.1016\/j.neurol.2022.03.004_bib0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199909233411311","article-title":"Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's Disease","volume":"341","author":"Freeman","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.neurol.2022.03.004_bib0185","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475","volume":"73","author":"Rosser","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.03.004_bib0190","article-title":"Vocal markers from sustained phonation in Huntington's Disease","author":"Riad","year":"2020","journal-title":"arXiv preprint"},{"issue":"7","key":"10.1016\/j.neurol.2022.03.004_bib0195","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1474-4422(12)70064-9","article-title":"Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations","volume":"11","author":"Galpern","year":"2012","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.neurol.2022.03.004_bib0200","doi-asserted-by":"crossref","first-page":"pe0145842","DOI":"10.1371\/journal.pone.0145842","article-title":"How to capitalize on the retest effect in future trials on Huntington's Disease","volume":"10","author":"Schramm","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neurol.2022.03.004_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128209","article-title":"Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting","volume":"10","author":"Cleret de Langavant","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurol.2022.03.004_bib0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12324-0","article-title":"MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates","volume":"10","author":"Aron Badin","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.neurol.2022.03.004_bib0215","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/MOT.0000000000000344","article-title":"Indications and prospects of neural transplantation for chronic neurological diseases","volume":"21","author":"Vadori","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"issue":"9","key":"10.1016\/j.neurol.2022.03.004_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161106","article-title":"COMT Val158Met Polymorphism Modulates Huntington's Disease Progression","volume":"11","author":"de Diego-Balaguer","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neurol.2022.03.004_bib0225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/stem.772","article-title":"The role of human leukocyte antigen matching in the development of multiethnic \u201chaplobank\u201d of induced pluripotent stem cell lines","volume":"30","author":"Gourraud","year":"2012","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.neurol.2022.03.004_bib0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mds.870110205","article-title":"Core assessement program for intracerebral transplantation in Huntington's Disease (CAPIT-HD)","volume":"11","author":"Quinn","year":"1996","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1016\/j.neurol.2022.03.004_bib0235","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/mds.26675","article-title":"Rating scales for behavioral symptoms in Huntington's disease: critique and recommendations","volume":"31","author":"Mestre","year":"2016","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurol.2022.03.004_bib0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mds.27227","article-title":"Rating scales for cognition in Huntington's disease: critique and recommendations","volume":"33","author":"Mestre","year":"2018","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2022.03.004_bib0245","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","article-title":"The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease","volume":"84","author":"Barker","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.neurol.2022.03.004_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253064","article-title":"Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT)","volume":"16","author":"Lunven","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neurol.2022.03.004_bib0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.03.004_bib0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/978-1-4939-7825-0_21","article-title":"CRISPR\/Cas9-Mediated Genome Editing for Huntington's Disease","volume":"1780","author":"Vachey","year":"2018","journal-title":"Methods Mol Biol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722005525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722005525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:03:38Z","timestamp":1777395818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378722005525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0035378722005525"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.03.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What did we learn from neural grafts in Huntington disease?","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}